Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bivalirudin in Acute Myocardial Infarction vs Glycoprotein IIb/IIIa and Heparin Undergoing Angioplasty (BRIGHT):a Randomised Controlled Trial

NCT01696110 is registered in ClinicalTrials.gov with Shenyang Northern Hospital as lead sponsor.

NCT NCT01696110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01696110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bivalirudin in Acute Myocardial Infarction vs Glycoprotein IIb/IIIa and Heparin Undergoing Angioplasty (BRIGHT):a Randomised Controlled Trial
Lead sponsor
Shenyang Northern Hospital
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2012
Completion date
July 31, 2014
Enrollment
2,194 (actual)
Sites
81

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction, percutaneous coronary intervention